Serum neurofilament light chain levels in MS: a promising biomarker of clinical and subclinical disease severity.

被引：0
|
作者：
Disanto, G. [1 ]
Barro, C. [2 ,3 ]
Giardiello, A. [1 ]
Gobbi, C. [1 ]
Zecca, C. [1 ]
Kuhle, J. [2 ,3 ]
机构：
[1] Neuroctr Southern Switzerland, Lugano, Switzerland
[2] Univ Hosp, Basel, Switzerland
[3] Univ Basel, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1602
引用
收藏
页码：845 / 845
页数：1
相关论文
共 50 条
  • [1] Value of serum neurofilament light chain levels as a biomarker of suboptimal treatment response in MS clinical practice
    Yaldizli, O.
    Benkert, P.
    Maceski, A.
    Barakovic, M.
    Todea, R. -A.
    Cagol, A.
    Schaedelin, S.
    Disanto, G.
    Oechtering, J.
    Orleth, A.
    Rey, D.
    Sinnecker, T.
    Rahmanzadeh, R.
    Zadic, S.
    Galbusera, R.
    Achtnichts, L.
    Aeschbacher, S.
    Chan, A.
    Conen, D.
    Derfuss, T.
    Findling, O.
    Fischer-Barnicol, B.
    Hrusovsky, K.
    Kropshofer, H.
    Lalive, P.
    Lieb, J.
    Lorscheider, J.
    Maggi, P.
    Mueller, C.
    Mueller, S.
    Naegelin, Y.
    Mueller, J.
    Oksenberg, J.
    Pot, C.
    Du Pasquier, R.
    Radue, E. -W.
    Salmen, A.
    Vehoff, J.
    Waubant, E.
    Wellmann, S.
    Wiendl, H.
    Wuerfel, J.
    Zecca, C.
    Berger, K.
    Gobbi, C.
    Kappos, L.
    Leppert, D.
    Granziera, C.
    Kuhle, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 26 - 27
  • [2] Value of serum neurofilament light chain levels as a biomarker of suboptimal treatment response in MS clinical practice.
    Yaldizli, O.
    Barro, C.
    Michalak, Z.
    Vehoff, J.
    Lascano, A. M.
    Disanto, G.
    Salmen, A.
    Derfuss, T.
    Granziera, C.
    Achtnichts, L.
    Findling, O.
    Nedeltchev, K.
    Kamm, C. P.
    Pot, C.
    Schluep, M.
    Du Pasquier, R.
    von Wyl, V.
    Wuerfel, J.
    Vallejo, V.
    Chan, A.
    Zecca, C.
    Gobbi, C.
    Lalive, P. H.
    Mueller, S.
    Kappos, L.
    Benkert, P.
    Kuhle, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 97 - 98
  • [3] Monitoring of Subclinical Disease Activity by Serum Neurofilament Light Chain Levels in Multiple Sclerosis
    Uher, Tomas
    Schaedelin, Sabine
    Benova, Barbora
    Barro, Christian
    Bergsland, Niels
    Dwyer, Michael
    Tyblova, Michaela
    Kucerova, Karolina
    Benkert, Pascal
    Michalak, Zuzanna
    Leppert, David
    Naegelin, Yvonne
    Krasensky, Jan
    Seidl, Zdenek
    Vaneckova, Manuela
    Havrdova, Eva Kubala
    Kappos, Ludwig
    Zivadinov, Robert
    Horakova, Dana
    Kuhle, Jens
    Kalincik, Tomas
    NEUROLOGY, 2019, 92 (15)
  • [4] Serum neurofilament light chain levels as multiple sclerosis biomarker
    Abd-ElHady, Mohamed E.
    Hashish, Ehab
    Yassine, Imane
    Anani, Maha
    Negm, Mohamed
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2024, 28 (02) : 28 - 32
  • [5] Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3
    Li, Quan-Fu
    Dong, Yi
    Yang, Lu
    Xie, Juan-Juan
    Ma, Yin
    Du, Yi-Chu
    Cheng, Hao-Ling
    Ni, Wang
    Wu, Zhi-Ying
    MOLECULAR NEURODEGENERATION, 2019, 14 (01)
  • [6] Investigation of serum neurofilament light chain as a biomarker in Fabry disease
    Ponleitner, Markus
    Gatterer, Constantin
    Bsteh, Gabriel
    Rath, Jakob
    Altmann, Patrick
    Berger, Thomas
    Graf, Senta
    Sunder-Plassmann, Gere
    Rommer, Paulus Stefan
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3
    Quan-Fu Li
    Yi Dong
    Lu Yang
    Juan-Juan Xie
    Yin Ma
    Yi-Chu Du
    Hao-Ling Cheng
    Wang Ni
    Zhi-Ying Wu
    Molecular Neurodegeneration, 14
  • [8] Serum neurofilament light chain protein: A promising biomarker for lacunar stroke and cerebral small vessel disease
    Gattringer, T.
    Pinter, D.
    Enzinger, C.
    Kneihsl, M.
    Fandler, S.
    Pichler, A.
    Barro, C.
    Groebke, S.
    Voortman, M.
    Seifert-Held, T.
    Pirpamer, L.
    Hofer, E.
    Ropele, S.
    Schmidt, R.
    Kuhle, J.
    Fazekas, F.
    Khalil, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 462 - 462
  • [9] Neurofilament light chain levels in MS At the doorstep of clinical application
    Dalmau, Josep
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2019, 6 (05):
  • [10] Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
    Kuhle, Jens
    Barro, Christian
    Disanto, Giulio
    Mathias, Amandine
    Soneson, Charlotte
    Bonnier, Guillaume
    Yaldizli, Oezguer
    Regeniter, Axel
    Derfuss, Tobias
    Canales, Mathieu
    Schluep, Myriam
    Du Pasquier, Renaud
    Krueger, Gunnar
    Granziera, Cristina
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (12) : 1550 - 1559
12345